Imagen de Portada

Increased Donor‐Derived Cell‐Free DNA as a Predictor for the Early Detection of Antibody‐Mediated Rejection Following Heart Transplantation

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Dana Dlouha, Sarka Chytilova, Jevgenija Vymetalova, Eva Rohlova, Marianna Lukasova, Sarka Novakova, Jaroslav Alois Hubacek
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Clinical Transplantation
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Sirolimus Versus Mycophenolate Mofetil in Simultaneous Pancreas–Kidney Transplantation: Impact on Urinary Tract Infection Rates
por: Barbora Píšová, et al.
Publicado: (2026)

Donor‐Derived Cell‐Free DNA as a Marker for the Efficacy of Daratumumab in Patients With Antibody‐Mediated Rejection Post‐Heart Transplantation: A Case Series
por: Anusha Konduri, et al.
Publicado: (2025)

Daratumumab for Anti‐ HLA Antibody Desensitization and Antibody Mediated Rejection in Pediatric Heart Transplant Patients
por: Caitlin Milligan, et al.
Publicado: (2025)

Severe Flash Pulmonary Edema Following Rituximab and Daratumumab Infusion for Post‐Transplant Antibody‐Mediated Rejection
por: Zeynab Rajabi, et al.
Publicado: (2025)

Tocilizumab as Adjuvant Therapy in Refractory Antibody Mediated Rejection in Pediatric Kidney Transplant Recipients
por: Anne M. Durkan, et al.
Publicado: (2025)

Daratumumab for Treatment of Acute Antibody‐Mediated Rejection in a Pediatric Kidney Transplant Recipient
por: Hailey Connolly, et al.
Publicado: (2025)

Low Incidence of Rejection and De Novo Donor‐Specific Antibody Formation Following COVID ‐19 Vaccination or Infection Among Pediatric Kidney Transplant Recipients
por: Helen Pizzo, et al.
Publicado: (2025)

Donor‐Derived Cell‐Free DNA Levels and Prediction of Resolution of Rejection in Kidney Transplant Recipients
por: Elaine Ku, et al.
Publicado: (2026)

Clinical Utility of Donor‐Derived Cell‐Free DNA in Heart Transplant Recipients With Multi‐Organ Transplants
por: Cathrine M. Moeller, et al.
Publicado: (2024)

Donor‐Derived Cell‐Free DNA for Diagnosing Subclinical Rejection: A Pilot Multicenter Study in Japanese Living‐Donor Kidney Transplantation
por: Toshihito Hirai, et al.
Publicado: (2025)

The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients
por: Qingyong Xu, et al.
Publicado: (2026)

Increasing Multiorgan Heart Transplantations From Donation After Circulatory Death Donors in the United States
por: Shivank Madan, et al.
Publicado: (2024)

Suitability of Infant Heart Transplant Recipients to Serve as Domino Partial Heart Transplant Donors
por: Meagan O. Rogers, et al.
Publicado: (2024)

Rethinking the Diagnosis and Management of Antibody‐Mediated Rejection in Multidisciplinary Transplant Meetings: A Global Survey and Banff Working Group Recommendations
por: Ruth Sapir‐Pichhadze, et al.
Publicado: (2025)

Long‐Term Chronic Lung Allograft Dysfunction‐Free Survival Following Lung Transplant in the Presence of Donor‐Specific Antibodies
por: Benjamin Grobman, et al.
Publicado: (2025)

Native BK Viral Nephropathy After Pediatric Heart Transplantation Treated With Bilateral Native Nephrectomy and Living Donor Kidney Transplantation: A Case Report
por: Kann Rachel, et al.
Publicado: (2025)

Effects of Nighttime Procurement and Transplantation on Outcomes Following Heart Transplantation
por: Yeahwa Hong, et al.
Publicado: (2025)

Mismatched Blood Types between Donors and Recipients Increase the Risk of BK Viremia One Year after Kidney Transplantation
por: Ruth Rahamimov, et al.
Publicado: (2026)

Predictors and Prognosis of Right Bundle Branch Block Following Heart Transplantation: A Systematic Review and Meta‐Analysis
por: Naydeen Mostafa, et al.
Publicado: (2025)

Donor Characteristics and Outcomes of Pediatric Heart Transplantation in South Korea
por: Susan Taejung Kim, et al.
Publicado: (2024)

Perspectives of Heart Transplant Patients and Providers on Acute Rejection Surveillance: A Mixed‐Methods Study
por: Hyoungmin Kim, et al.
Publicado: (2026)

Possible Donor‐Derived Tuberculosis in an Orthotopic Heart Transplant Recipient
por: Phani V. Akella, et al.
Publicado: (2026)

Alternative Measures of Body Composition and Outcomes Following Heart Transplant
por: Ana Lanier, et al.
Publicado: (2026)

Evolving Long‐Term Outcomes of Heart Transplantation Using COVID‐19 Positive Donors
por: Ye In Christopher Kwon, et al.
Publicado: (2026)

Combined Multiorgan Heart and Kidney Transplants With Single Donor Allografts: Simultaneous Versus Staged?
por: Jacqueline I. Kim, et al.
Publicado: (2026)

Outcomes of Donor‐Recipient Size Mismatch in Donation After Circulatory Death Heart Transplantation
por: Iris Feng, et al.
Publicado: (2025)

Routine screening for HLA Antibodies in Heart Transplant patients—Does it affect clinical decision making?
por: Tor Skibsted Clemmensen, et al.
Publicado: (2024)

Risk Factors and Outcomes of Reintubation Following Combined Heart‐Lung Transplantation
por: Ye In Christopher Kwon, et al.
Publicado: (2026)

Association Between High Sensitivity Troponin I and NTproBNP With Rejection and Graft Loss in Pediatric Heart Transplant Recipients
por: Defne A. Magnetta, et al.
Publicado: (2024)

Hiding in Plain Sight: Pulmonary Vein Stenosis Following Pediatric Heart Transplantation
por: Conor P. O'Halloran, et al.
Publicado: (2025)

Clinical Implication of Each Type of Arrhythmia in Pediatric Patients Following Heart Transplantation
por: Naoya Kataoka, et al.
Publicado: (2025)

Evolving Trends and Impact of Waitlist Transfusion on Recipient Outcomes Following Heart Transplantation
por: Yeahwa Hong, et al.
Publicado: (2024)

Rupture of Hepatic Hemangioma Following Living Donor Liver Transplantation: A Case Report
por: João Seda Neto, et al.
Publicado: (2025)

Does Severity of Donor Acute Kidney Injury Influence Outcomes Following Kidney Transplantation?
por: Alexandra R. Monetti, et al.
Publicado: (2024)

Persistent Chronic Active T‐Cell‐Mediated Rejection After Kidney Transplantation Is Associated With Poor Allograft Survival
por: Hiroshi Noguchi, et al.
Publicado: (2024)

Time Well Spent: Clinical Predictors of Days Alive and Out of the Hospital After Heart Transplantation
por: Elissa Driggin, et al.
Publicado: (2025)

Intravenous Immunoglobulins Alone for the Desensitization of Lung Transplant Recipients with Preformed Donor Specific Antibodies and Negative Flow Cytometry Crossmatch
por: Rayid Abdulqawi, et al.
Publicado: (2024)

Donor‐Derived Strongyloides Infection Leading to Hyperinfection Syndrome in a Heart Transplant Recipient
por: Ana Khazan, et al.
Publicado: (2026)

Generic Versus Brand‐Name Immunosuppression Following Heart Transplant: An Analysis of the UNOS Database
por: Aviral Mahajan, et al.
Publicado: (2025)

Impact of Donor and Recipient Sex on Long‐Term Outcomes Following Living Donor Kidney Transplantation: A Retrospective Dual‐Center Study
por: Yitian Fang, et al.
Publicado: (2025)